\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ physical\\ exam\\,\\ a\\ hard\\ mass\\ was\\ palpable\\ on\\ the\\ medial\\ aspect\\ of\\ the\\ left\\ amputation\\ site\\.\ \(0\)\
\-\ patient\\ was\\ taken\\ to\\ the\\ operating\\ room\\ for\\ resection\\ of\\ the\\ heterotopic\\ ossification\\.\\ \\ after\\ resection\\,\\ patient\\'s\\ complaint\\ of\\ pain\\ with\\ prosthesis\\ use\\ was\\ relieved\\.\ \(0\)\
\-\ preoperative\\ anteroposterior\\ and\\ lateral\\ radiographs\\ of\\ left\\ knee\\ shows\\ through\\-knee\\-amputation\\ with\\ irregularly\\ bordered\\ heterogeneous\\ ossified\\ densities\\ juxtaposed\\ to\\ the\\ posteromedial\\ aspect\\ of\\ the\\ distal\\ femur\\.\\ \\ these\\ ossifications\\ extend\\ through\\ the\\ soft\\ tissues\\ and\\ are\\ consistent\\ with\\ heterotopic\\ ossification\\.\\ \\ the\\ left\\ femur\\ shows\\ normal\\ bone\\ density\\.\\ \\ the\\ remainder\\ of\\ the\\ soft\\ tissues\\ appear\\ normal\\.\ \(0\)\
\-\ postoperative\\ anterioposterior\\ and\\ lateral\\ radiographs\\ of\\ left\\ knee\\ shows\\ through\\-knee\\-amputation\\ with\\ small\\ residual\\ focal\\ ossified\\ densities\\ near\\ the\\ medial\\ epicondyle\\ and\\ the\\ medial\\ condyle\\.\\ \\ the\\ posterior\\ aspect\\ of\\ the\\ distal\\ femur\\ also\\ shows\\ focal\\ area\\ of\\ ossified\\ densities\\.\\ \\ a\\ percutaneous\\ drain\\ is\\ in\\ place\\ in\\ the\\ soft\\ tissue\\ distal\\ to\\ the\\ medial\\ condyle\\.\\ \\ postoperative\\ air\\ is\\ seen\\ in\\ the\\ soft\\ tissues\\.\ \(0\)\
\-\ heterotopic\\ ossification\ \(17\)\
\-\ the\\ history\\ of\\ trauma\\ combined\\ with\\ the\\ clinical\\ course\\ and\\ radiographic\\ findings\\ of\\ the\\ ossifications\\ in\\ the\\ soft\\ tissue\\ are\\ characteristic\\ of\\ heterotopic\\ officiation\\.\ \(0\)\
\-\ 29\\ year\\ old\\ active\\ duty\\ usmc\\ male\\ who\\ sustained\\ an\\ improvised\\ explosive\\ device\\ \\(ied\\)\\ blast\\ to\\ bilateral\\ lower\\ extremities\\ and\\ who\\ eventually\\ required\\ a\\ through\\-knee\\-amputation\\ in\\ march\\ 2005\\.\\ \\ in\\ january\\ 2006\\ patient\\ was\\ seen\\ in\\ the\\ orthopedic\\ clinic\\ with\\ complaints\\ of\\ pain\\ in\\ left\\ amputation\\ site\\ with\\ prosthesis\\ use\\.\\ \\ patient\\ denied\\ fevers\\,\\ chills\\,\\ night\\ sweats\\,\\ or\\ weight\\ loss\\.\ \(0\)\
\-\ heterotopic\\ ossification\\ \\(ho\\)\\ is\\ the\\ formation\\ of\\ bone\\ in\\ abnormal\\ locations\\.\\(1\\-7\\)\\ \\ ho\\ is\\ a\\ well\\-acknowledged\\ entity\\ that\\ is\\ commonly\\ divided\\ into\\ three\\ categories\\:\\ genetic\\,\\ traumatic\\,\\ and\\ neurogenic\\.\\ \\ ho\\ has\\ recently\\ become\\ a\\ significant\\ problem\\ for\\ the\\ many\\ amputees\\ from\\ operation\\ enduring\\ freedom\\ \\(oef\\)\\ and\\ operation\\ iraqi\\ freedom\\ \\(oif\\)\\.\\(1\\)\ \(0\)\
\-\ ho\\ occurs\\ frequently\\ in\\ many\\ traumatic\\ events\\ including\\ spinal\\ cord\\ injuries\\ \\(20\\%\\ \\-\\ 30\\%\\)\\,\\ closed\\ head\\ injuries\\ \\(10\\%\\ \\-\\ 20\\%\\)\\,\\ fractures\\,\\ dislocations\\,\\ and\\ burns\\.\\ \\ ho\\ also\\ frequently\\ occurs\\ after\\ various\\ medical\\ interventions\\ such\\ as\\ amputation\\ \\(62\\%\\)\\,\\ total\\ hip\\ arthroscopy\\ \\(43\\%\\)\\ and\\ open\\ reduction\\ internal\\ fixation\\.\\(1\\-3\\)\\ \\ more\\ rare\\ causes\\ of\\ ho\\ that\\ have\\ been\\ reported\\ include\\ encephalitis\\,\\ meningitis\\,\\ tetanus\\,\\ brain\\ tumors\\,\\ epidural\\ abscess\\,\\ and\\ subarachnoid\\ hemorrhage\\.\\(3\\)\ \(0\)\
\-\ ho\\ is\\ believed\\ to\\ originate\\ from\\ inappropriate\\ recruitment\\ or\\ differentiation\\ of\\ pluripotent\\ mesenchymal\\ cells\\ into\\ osteogenic\\ cells\\.\\ \\ two\\ factors\\ proposed\\ to\\ induce\\ this\\ recruitment\\ or\\ differentiation\\ are\\ bone\\ morphogenic\\ protein\\-4\\ \\(bmp\\-4\\)\\ and\\ prostaglandins\\ e2\\ \\(pge2\\)\\.\\(1\\,2\\,4\\)\\ various\\ risk\\ factors\\ have\\ been\\ identified\\ for\\ the\\ development\\ of\\ ho\\ including\\ male\\ gender\\,\\ history\\ of\\ ho\\,\\ hypertrophic\\ osteoarthritis\\,\\ ankylosing\\ spondylitis\\,\\ multiple\\ injuries\\,\\ and\\ lateral\\ approach\\ in\\ total\\ hip\\ arthroscopy\\.\\(3\\)\ \(0\)\
\-\ most\\ patients\\ with\\ ho\\ are\\ completely\\ asymptomatic\\.\\ \\ patients\\ who\\ are\\ symptomatic\\ commonly\\ complain\\ initially\\ of\\ nonspecific\\ signs\\ and\\ symptoms\\ including\\ fever\\,\\ erythema\\,\\ swelling\\,\\ and\\ pain\\.\\ \\ later\\,\\ they\\ begin\\ to\\ complain\\ of\\ decreased\\ joint\\ mobility\\ and\\ continued\\ pain\\ despite\\ improvement\\ of\\ their\\ fever\\,\\ erythema\\,\\ and\\ swelling\\.\\(2\\)\\ \\ many\\ traumatic\\ amputees\\ with\\ ho\\ complain\\ of\\ pain\\ with\\ prostheses\\ use\\.\\(1\\)\ \(0\)\
\-\ ho\\ is\\ most\\ commonly\\ diagnosed\\ incidentally\\ on\\ plain\\ radiographs\\.\\ \\ the\\ typical\\ radiographic\\ appearance\\ of\\ ho\\,\\ when\\ mature\\,\\ is\\ focal\\ distinctive\\ ossifications\\ in\\ the\\ muscle\\ and\\ other\\ soft\\ tissue\\.\\ \\ they\\ also\\ may\\ be\\ contiguous\\ with\\ the\\ periosteum\\ of\\ bone\\.\\ \\ four\\ to\\ six\\ weeks\\ after\\ the\\ inciting\\ event\\,\\ plain\\ radiographs\\ usually\\ show\\ mature\\ ho\\ lesions\\.\\ \\ although\\ plain\\ radiographs\\ are\\ adequate\\ to\\ diagnosis\\ ho\\,\\ three\\-phase\\ bone\\ scintigraphy\\ has\\ been\\ shown\\ to\\ be\\ able\\ to\\ detect\\ ho\\ earlier\\ \\(2\\.5\\ weeks\\ after\\ inciting\\ event\\)\\.\\(2\\,5\\)\\ \\ alkaline\\ phosphatase\\ and\\ 24\\-hour\\ pge2\\ urinary\\ excretion\\ are\\ also\\ used\\ as\\ an\\ adjunct\\ in\\ diagnosing\\ ho\\.\\(2\\)\ \(0\)\
\-\ common\\ complications\\ of\\ ho\\ needing\\ intervention\\ include\\ decreased\\ range\\-of\\-motion\\,\\ pain\\,\\ peripheral\\ nerve\\ entrapments\\,\\ and\\ pressure\\ ulcers\\.\\ \\ traumatic\\ amputees\\ with\\ ho\\ have\\ the\\ additional\\ complication\\ with\\ prosthesis\\ fitting\\.\\(1\\)\ \(0\)\
\-\ management\\ of\\ ho\\ is\\ controversial\\ with\\ new\\ therapies\\ on\\ the\\ horizon\\.\\ \\ the\\ most\\ common\\ management\\ strategies\\ for\\ ho\\ are\\ radiation\\ therapy\\ and\\ nsaids\\.\\ \\ numerous\\ studies\\ have\\ been\\ conducted\\ evaluating\\ the\\ efficacy\\ of\\ both\\ radiation\\ therapy\\ and\\ nsaids\\ as\\ well\\ as\\ comparing\\ the\\ efficacy\\ between\\ the\\ two\\ management\\ strategies\\.\\ \\ there\\ does\\ not\\ appear\\ to\\ be\\ a\\ difference\\ between\\ the\\ efficacy\\ of\\ radiation\\ therapy\\ and\\ nsaids\\ in\\ preventing\\ ho\\ development\\.\\ \\ seven\\ gy\\ of\\ radiation\\ therapy\\ is\\ commonly\\ given\\ within\\ 24\\ hours\\ pre\\-operation\\ of\\ total\\ hip\\ arthroplasty\\.\\ \\ there\\ is\\ no\\ consensus\\ of\\ which\\ nsaid\\ is\\ most\\ effective\\,\\ but\\ commonly\\ a\\ 5\\-6\\ week\\ period\\ of\\ nsaids\\ is\\ administered\\ post\\-operation\\.\\(6\\)\\ \\ resection\\ is\\ the\\ last\\ management\\ modality\\ that\\ is\\ used\\ with\\ symptomatic\\ ho\\.\\ \\ resection\\ is\\ usually\\ done\\ only\\ after\\ radiologic\\ and\\ laboratory\\ evidence\\ of\\ metabolic\\ inactivity\\ of\\ the\\ ho\\.\\(2\\)\\ \\ various\\ animal\\ studies\\ have\\ shown\\ promise\\ for\\ a\\ bmp\\-4\\ antagonist\\ \\(noggin\\)\\ for\\ those\\ who\\ are\\ at\\ risk\\ for\\ ho\\ development\\.\\(4\\)\ \(0\)\
\-\ references\ \(24\)\
\-\ 1\\.\\ potter\\ bk\\,\\ burns\\ tc\\,\\ lacap\\ ap\\,\\ granville\\ rr\\,\\ gajewski\\ d\\.\\ \\ heterotopic\\ ossification\\ in\\ the\\ residual\\ limbs\\ of\\ traumatic\\ and\\ combat\\-related\\ amputees\\.\\ \\ jaaos\\ 2006\\;\\ 14\\:s191\\-s197\\.\ \(0\)\
\-\ 2\\.\\ shehab\\ d\\,\\ elgazzar\\ ah\\,\\ collier\\ bd\\.\\ \\ heterotopic\\ ossification\\.\\ \\ j\\ nucl\\ med\\ 2002\\;\\ 43\\:346\\-353\\.\ \(0\)\
\-\ 3\\.\\ balboni\\ ta\\,\\ gobezie\\ r\\,\\ mamon\\ hj\\.\\ \\ heterotopic\\ ossification\\:\\ pathophysiology\\,\\ clinical\\ features\\,\\ and\\ the\\ role\\ of\\ radiotherapy\\ for\\ prophylaxis\\.\\ \\ int\\ j\\ radiation\\ oncology\\ biol\\ phys\\ 2006\\;\\ 65\\:\\ 1289\\-1299\\.\ \(0\)\
\-\ 4\\.\\ kaplan\\ fs\\,\\ glaser\\ dl\\,\\ hebela\\ n\\,\\ shore\\ em\\.\\ \\ heterotopic\\ ossification\\.\\ \\ jaaos\\ 2004\\;\\ 12\\:116\\-125\\.\ \(0\)\
\-\ 5\\.\\ henrot\\ p\\,\\ stines\\ j\\,\\ walter\\ f\\,\\ martinet\\ n\\,\\ paysant\\ j\\,\\ blum\\ a\\.\\ \\ imaging\\ of\\ the\\ painful\\ lower\\ limb\\ stump\\.\\ \\ radiographics\\ 2000\\;\\ 20\\:s219\\-235\\.\ \(0\)\
\-\ 6\\.\\ burd\\ ta\\,\\ lowry\\ kj\\,\\ anglen\\ jo\\.\\ \\ indomethacin\\ compared\\ with\\ localized\\ irradiation\\ for\\ the\\ prevention\\ of\\ heterotopic\\ ossification\\ following\\ surgical\\ treatment\\ of\\ acetabular\\ fractures\\.\\ \\ jbjs\\ \\(am\\)\\ 2001\\;\\ 83\\:1783\\-1788\\.\ \(0\)\
\-\ 7\\.\\ iorio\\ r\\,\\ healy\\ wl\\.\\ \\ heterotopic\\ ossification\\ after\\ hip\\ and\\ knee\\ arthroplasty\\:\\ risk\\ factors\\,\\ prevention\\,\\ and\\ treatment\\.\\ \\ jaaos\\ 2002\\;\\ 10\\:409\\-416\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ho\\:\\ 0\\.14415146341347995\ \(0\)\
\-\ heterotopic\\:\\ 0\\.04995283143845669\ \(0\)\
\-\ ossification\\:\\ 0\\.038977372951377286\ \(0\)\
\-\ amputees\\:\\ 0\\.031682006914524705\ \(0\)\
\-\ through\\-knee\\-amputation\\:\\ 0\\.02376150518589353\ \(0\)\
\-\ jaaos\\:\\ 0\\.021893183944492058\ \(0\)\
\-\ ossifications\\:\\ 0\\.01942339760520862\ \(0\)\
\-\ \\(\\:\\ 0\\.01752359982801818\ \(0\)\
\-\ \\)\\:\\ 0\\.017309539700861847\ \(0\)\
\-\ nsaids\\:\\ 0\\.016570802532167233\ \(0\)\
\-\ prosthesis\\:\\ 0\\.01628822022028765\ \(0\)\
\-\ efficacy\\:\\ 0\\.016124811536146314\ \(0\)\
\-\ traumatic\\:\\ 0\\.01607851060708243\ \(0\)\
\-\ recruitment\\:\\ 0\\.015841003457262352\ \(0\)\
\-\ bmp\\-4\\:\\ 0\\.015841003457262352\ \(0\)\
\-\ pge2\\:\\ 0\\.015841003457262352\ \(0\)\
\-\ ossified\\:\\ 0\\.015429854368216126\ \(0\)\
\-\ amputation\\:\\ 0\\.015085290024523712\ \(0\)\
\-\ commonly\\:\\ 0\\.014485765693870806\ \(0\)\
\-\ complain\\:\\ 0\\.014419898978886177\ \(0\)\
\-\ \\,\\:\\ 0\\.014350308953746591\ \(0\)\
\-\ j\\:\\ 0\\.013871307695831942\ \(0\)\
\-\ freedom\\:\\ 0\\.013866857385980933\ \(0\)\
\-\ strategies\\:\\ 0\\.013349908468727058\ \(0\)\
\-\ 2006\\:\\ 0\\.013271423519827148\ \(0\)\
\-\ densities\\:\\ 0\\.012770838221188083\ \(0\)\
\-\ \\;\\:\\ 0\\.01273849804058235\ \(0\)\
\-\ various\\:\\ 0\\.012725536015483553\ \(0\)\
\-\ radiation\\:\\ 0\\.012597714508366291\ \(0\)\
\-\ burns\\:\\ 0\\.012344309568573558\ \(0\)\
\-\ ta\\:\\ 0\\.012344309568573558\ \(0\)\
\-\ hip\\:\\ 0\\.012233144194470651\ \(0\)\
\-\ radiographs\\:\\ 0\\.012157550948796643\ \(0\)\
\-\ management\\:\\ 0\\.011588612555096646\ \(0\)\
\-\ inciting\\:\\ 0\\.011375762397445638\ \(0\)\
\-\ soft\\:\\ 0\\.011217934037701079\ \(0\)\
\-\ prevention\\:\\ 0\\.010974785665524327\ \(0\)\
\-\ injuries\\:\\ 0\\.010747182443838807\ \(0\)\
\-\ \\%\\:\\ 0\\.010745665947956916\ \(0\)\
\-\ arthroscopy\\:\\ 0\\.010647163820431868\ \(0\)\
\-\ arthroplasty\\:\\ 0\\.010457836748270454\ \(0\)\
\-\ factors\\:\\ 0\\.010347128521687126\ \(0\)\
\-\ development\\:\\ 0\\.010031720278058587\ \(0\)\
\-\ operation\\:\\ 0\\.00998638254437559\ \(0\)\
\-\ femur\\:\\ 0\\.009950281521733799\ \(0\)\
\-\ total\\:\\ 0\\.009918382714059936\ \(0\)\
\-\ medial\\:\\ 0\\.009823178844887879\ \(0\)\
\-\ resection\\:\\ 0\\.009577414754789645\ \(0\)\
\-\ bone\\:\\ 0\\.009539239359657996\ \(0\)\
\-\ after\\:\\ 0\\.009531003787650687\ \(0\)\
\-\ many\\:\\ 0\\.009466882792203295\ \(0\)\
\-\ tissues\\:\\ 0\\.009453506001523702\ \(0\)\
\-\ are\\:\\ 0\\.009419465276519691\ \(0\)\
\-\ mature\\:\\ 0\\.00925778396736182\ \(0\)\
\-\ use\\:\\ 0\\.009103609474510251\ \(0\)\
\-\ postoperative\\:\\ 0\\.008922499231368267\ \(0\)\
\-\ n\\:\\ 0\\.008922499231368267\ \(0\)\
\-\ event\\:\\ 0\\.008483690676989035\ \(0\)\
\-\ shows\\:\\ 0\\.008443391553383212\ \(0\)\
\-\ 2002\\:\\ 0\\.00839601742601072\ \(0\)\
\-\ been\\:\\ 0\\.008355058003464479\ \(0\)\
\-\ knee\\:\\ 0\\.008351727014987268\ \(0\)\
\-\ risk\\:\\ 0\\.008342875060267079\ \(0\)\
\-\ including\\:\\ 0\\.008316492293781466\ \(0\)\
\-\ have\\:\\ 0\\.00831283952544965\ \(0\)\
\-\ 20\\:\\ 0\\.008281712226838317\ \(0\)\
\-\ therapy\\:\\ 0\\.008210748593856652\ \(0\)\
\-\ condyle\\:\\ 0\\.008181201342183617\ \(0\)\
\-\ differentiation\\:\\ 0\\.008181201342183617\ \(0\)\
\-\ is\\:\\ 0\\.008083245691065239\ \(0\)\
\-\ who\\:\\ 0\\.008007074246690754\ \(0\)\
\-\ officiation\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ 1\\-7\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ well\\-acknowledged\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ enduring\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ oef\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ pluripotent\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ protein\\-4\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ 1\\,2\\,4\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ post\\-operation\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ noggin\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ lacap\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ granville\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ gajewski\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ combat\\-related\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ s191\\-s197\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ shehab\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ elgazzar\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ 43\\:346\\-353\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ balboni\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ gobezie\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ mamon\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ 1289\\-1299\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ glaser\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ hebela\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ 12\\:116\\-125\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ henrot\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ stines\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ martinet\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ paysant\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ s219\\-235\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ burd\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ lowry\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ anglen\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ 83\\:1783\\-1788\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ iorio\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ 10\\:409\\-416\\:\\ 0\\.007920501728631176\ \(0\)\
\-\ residual\\:\\ 0\\.007620498554291313\ \(0\)\
\-\ erythema\\:\\ 0\\.0075478848286167815\ \(0\)\
\-\ plain\\:\\ 0\\.007480495182450363\ \(0\)\
\-\ anterioposterior\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ morphogenic\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ 2\\,5\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ range\\-of\\-motion\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ entrapments\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ horizon\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ pre\\-operation\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ inactivity\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ antagonist\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ collier\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ biol\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ shore\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ blum\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ healy\\:\\ 0\\.0072977279814973525\ \(0\)\
\-\ aspect\\:\\ 0\\.00723528823310878\ \(0\)\
\-\ most\\:\\ 0\\.00709015324969659\ \(0\)\
\-\ r\\:\\ 0\\.006974024242292555\ \(0\)\
\-\ juxtaposed\\:\\ 0\\.006933428692990466\ \(0\)\
\-\ usmc\\:\\ 0\\.006933428692990466\ \(0\)\
\-\ prostaglandins\\:\\ 0\\.006933428692990466\ \(0\)\
\-\ ah\\:\\ 0\\.006933428692990466\ \(0\)\
\-\ jo\\:\\ 0\\.006933428692990466\ \(0\)\
\-\ jbjs\\:\\ 0\\.006933428692990466\ \(0\)\
\-\ wl\\:\\ 0\\.006933428692990466\ \(0\)\
\-\ iraqi\\:\\ 0\\.006674954234363529\ \(0\)\
\-\ e2\\:\\ 0\\.006674954234363529\ \(0\)\
\-\ potter\\:\\ 0\\.006674954234363529\ \(0\)\
\-\ bk\\:\\ 0\\.006674954234363529\ \(0\)\
\-\ kaplan\\:\\ 0\\.006674954234363529\ \(0\)\
\-\ frequently\\:\\ 0\\.0066550415734231\ \(0\)\
\-\ focal\\:\\ 0\\.006578149876383833\ \(0\)\
\-\ site\\:\\ 0\\.006489688655686798\ \(0\)\
\-\ oif\\:\\ 0\\.0064744658684028735\ \(0\)\
\-\ promise\\:\\ 0\\.0064744658684028735\ \(0\)\
\-\ hj\\:\\ 0\\.0064744658684028735\ \(0\)\
\-\ stump\\:\\ 0\\.0064744658684028735\ \(0\)\
\-\ kj\\:\\ 0\\.0064744658684028735\ \(0\)\
\-\ tetanus\\:\\ 0\\.006310654945856643\ \(0\)\
\-\ induce\\:\\ 0\\.006310654945856643\ \(0\)\
\-\ needing\\:\\ 0\\.006310654945856643\ \(0\)\
\-\ fitting\\:\\ 0\\.006310654945856643\ \(0\)\
\-\ bd\\:\\ 0\\.006310654945856643\ \(0\)\
\-\ nucl\\:\\ 0\\.006310654945856643\ \(0\)\
\-\ walter\\:\\ 0\\.006310654945856643\ \(0\)\
\-\ occurs\\:\\ 0\\.006302337334349135\ \(0\)\
\-\ appear\\:\\ 0\\.006284633297614164\ \(0\)\
\-\ distal\\:\\ 0\\.00626220643920762\ \(0\)\
\-\ bordered\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ 2005\\.\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ inappropriate\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ prostheses\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ three\\-phase\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ gy\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ animal\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ indomethacin\\:\\ 0\\.006172154784286779\ \(0\)\
\-\ cells\\:\\ 0\\.006157136916711586\ \(0\)\
\-\ shown\\:\\ 0\\.006157136916711586\ \(0\)\
\-\ symptomatic\\:\\ 0\\.0061005991459015495\ \(0\)\
\-\ \\:\\:\\ 0\\.006093125692672049\ \(0\)\
\-\ also\\:\\ 0\\.006054338162336573\ \(0\)\
\-\ distinctive\\:\\ 0\\.006052180487229706\ \(0\)\
\-\ dl\\:\\ 0\\.005946355657349757\ \(0\)\
\-\ em\\:\\ 0\\.005946355657349757\ \(0\)\
\-\ for\\:\\ 0\\.005895753223525998\ \(0\)\
\-\ used\\:\\ 0\\.005890717263158961\ \(0\)\
\-\ phys\\:\\ 0\\.00585169212126905\ \(0\)\
\-\ radiographic\\:\\ 0\\.005828148053528722\ \(0\)\
\-\ fractures\\:\\ 0\\.005814534767260154\ \(0\)\
\-\ improvised\\:\\ 0\\.005766058536539199\ \(0\)\
\-\ comparing\\:\\ 0\\.005766058536539199\ \(0\)\
\-\ nsaid\\:\\ 0\\.005766058536539199\ \(0\)\
\-\ int\\:\\ 0\\.005766058536539199\ \(0\)\
\-\ studies\\:\\ 0\\.005734952233206038\ \(0\)\
\-\ epicondyle\\:\\ 0\\.005687881198722819\ \(0\)\
\-\ 24\\-hour\\:\\ 0\\.005687881198722819\ \(0\)\
\-\ in\\:\\ 0\\.005679207953372708\ \(0\)\
\-\ pain\\:\\ 0\\.005625920040596953\ \(0\)\
\-\ explosive\\:\\ 0\\.005615965019321619\ \(0\)\
\-\ 1\\-3\\:\\ 0\\.005615965019321619\ \(0\)\
\-\ originate\\:\\ 0\\.005615965019321619\ \(0\)\
\-\ adjunct\\:\\ 0\\.005615965019321619\ \(0\)\
\-\ consensus\\:\\ 0\\.005615965019321619\ \(0\)\
\-\ irradiation\\:\\ 0\\.005615965019321619\ \(0\)\
\-\ osteogenic\\:\\ 0\\.005549381037152956\ \(0\)\
\-\ they\\:\\ 0\\.005532697442025707\ \(0\)\
\-\ 5\\-6\\:\\ 0\\.005487392832762164\ \(0\)\
\-\ fs\\:\\ 0\\.005487392832762164\ \(0\)\
\-\ 1\\:\\ 0\\.005480664064581421\ \(0\)\
\-\ tissue\\:\\ 0\\.005459356303106721\ \(0\)\
\-\ ied\\:\\ 0\\.0054294067400958825\ \(0\)\
\-\ tc\\:\\ 0\\.005374937178715438\ \(0\)\
\-\ blast\\:\\ 0\\.005275003993531049\ \(0\)\
\-\ posteromedial\\:\\ 0\\.005228918374135227\ \(0\)\
\-\ january\\:\\ 0\\.005228918374135227\ \(0\)\
\-\ categories\\:\\ 0\\.005228918374135227\ \(0\)\
\-\ preventing\\:\\ 0\\.005228918374135227\ \(0\)\
\-\ the\\:\\ 0\\.005216954139759464\ \(0\)\
\-\ fever\\:\\ 0\\.005195440478979275\ \(0\)\
\-\ events\\:\\ 0\\.005185081748646069\ \(0\)\
\-\ mesenchymal\\:\\ 0\\.005185081748646069\ \(0\)\
\-\ periosteum\\:\\ 0\\.005185081748646069\ \(0\)\
\-\ limbs\\:\\ 0\\.005185081748646069\ \(0\)\
\-\ gender\\:\\ 0\\.005143284789405375\ \(0\)\
\-\ therapies\\:\\ 0\\.005143284789405375\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.005143284789405375\ \(0\)\
\-\ swelling\\:\\ 0\\.0051155630978996095\ \(0\)\
\-\ anteroposterior\\:\\ 0\\.005103346098865542\ \(0\)\
\-\ interventions\\:\\ 0\\.005103346098865542\ \(0\)\
\-\ begin\\:\\ 0\\.005103346098865542\ \(0\)\
\-\ difference\\:\\ 0\\.005103346098865542\ \(0\)\
\-\ proposed\\:\\ 0\\.0050651074515889955\ \(0\)\
\-\ conducted\\:\\ 0\\.0050651074515889955\ \(0\)\
\-\ phosphatase\\:\\ 0\\.005028430008174571\ \(0\)\
\-\ controversial\\:\\ 0\\.005028430008174571\ \(0\)\
\-\ acetabular\\:\\ 0\\.005028430008174571\ \(0\)\
\-\ irregularly\\:\\ 0\\.004993191272187795\ \(0\)\
\-\ lateral\\:\\ 0\\.0049775419019529666\ \(0\)\
\-\ 2\\:\\ 0\\.004959850394907133\ \(0\)\
\-\ march\\:\\ 0\\.004959282621709047\ \(0\)\
\-\ excretion\\:\\ 0\\.004959282621709047\ \(0\)\
\-\ alkaline\\:\\ 0\\.004895078700790678\ \(0\)\
\-\ diagnosing\\:\\ 0\\.004895078700790678\ \(0\)\
\-\ oncology\\:\\ 0\\.004895078700790678\ \(0\)\
\-\ between\\:\\ 0\\.004867018034544913\ \(0\)\
\-\ mobility\\:\\ 0\\.00486461908562834\ \(0\)\
\-\ operating\\:\\ 0\\.00483515832837498\ \(0\)\
\-\ divided\\:\\ 0\\.00483515832837498\ \(0\)\
\-\ dislocations\\:\\ 0\\.00483515832837498\ \(0\)\
\-\ seven\\:\\ 0\\.004806632992962059\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.004806632992962059\ \(0\)\
\-\ neurogenic\\:\\ 0\\.004726118924058477\ \(0\)\
\-\ clinical\\:\\ 0\\.004724725606587609\ \(0\)\
\-\ preoperative\\:\\ 0\\.00470080816308211\ \(0\)\
\-\ entity\\:\\ 0\\.00470080816308211\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.004676190935599527\ \(0\)\
\-\ usually\\:\\ 0\\.004662943852411068\ \(0\)\
\-\ ankylosing\\:\\ 0\\.004652230246397227\ \(0\)\
\-\ detect\\:\\ 0\\.004652230246397227\ \(0\)\
\-\ as\\:\\ 0\\.0046453818720363985\ \(0\)\
\-\ device\\:\\ 0\\.00462889198368091\ \(0\)\
\-\ believed\\:\\ 0\\.0046061446270014034\ \(0\)\
\-\ to\\:\\ 0\\.004604507907741092\ \(0\)\
\-\ spondylitis\\:\\ 0\\.004583958991250845\ \(0\)\
\-\ decreased\\:\\ 0\\.004565600004895884\ \(0\)\
\-\ d\\.\\:\\ 0\\.004562308001512246\ \(0\)\
\-\ role\\:\\ 0\\.004541166494405153\ \(0\)\
\-\ and\\:\\ 0\\.004528528446093546\ \(0\)\
\-\ relieved\\:\\ 0\\.004520511042271552\ \(0\)\
\-\ ulcers\\:\\ 0\\.004520511042271552\ \(0\)\
\-\ radiographics\\:\\ 0\\.004500319797121455\ \(0\)\
\-\ locations\\:\\ 0\\.00448057235173172\ \(0\)\
\-\ hypertrophic\\:\\ 0\\.0044612496156841335\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.0044612496156841335\ \(0\)\
\-\ 2000\\:\\ 0\\.004442333704455174\ \(0\)\
\-\ contiguous\\:\\ 0\\.004423807839942382\ \(0\)\
\-\ administered\\:\\ 0\\.004423807839942382\ \(0\)\
\-\ med\\:\\ 0\\.004405656261040748\ \(0\)\
\-\ two\\:\\ 0\\.004397720103532805\ \(0\)\
\-\ sweats\\:\\ 0\\.004370417525053971\ \(0\)\
\-\ effective\\:\\ 0\\.004370417525053971\ \(0\)\
\-\ weeks\\:\\ 0\\.004358091207369539\ \(0\)\
\-\ sustained\\:\\ 0\\.00435330324385838\ \(0\)\
\-\ limb\\:\\ 0\\.004336508874575224\ \(0\)\
\-\ include\\:\\ 0\\.004307553437610578\ \(0\)\
\-\ a\\.\\:\\ 0\\.004303833542885309\ \(0\)\
\-\ left\\:\\ 0\\.004295171919465026\ \(0\)\
\-\ encephalitis\\:\\ 0\\.00428793095789034\ \(0\)\
\-\ evaluating\\:\\ 0\\.004272304953656855\ \(0\)\
\-\ combined\\:\\ 0\\.004241845338494517\ \(0\)\
\-\ hard\\:\\ 0\\.004226994213650663\ \(0\)\
\-\ drain\\:\\ 0\\.004226994213650663\ \(0\)\
\-\ eventually\\:\\ 0\\.004226994213650663\ \(0\)\
\-\ modality\\:\\ 0\\.004212384581241156\ \(0\)\
\-\ genetic\\:\\ 0\\.00419800871300536\ \(0\)\
\-\ problem\\:\\ 0\\.00419800871300536\ \(0\)\
\-\ 62\\:\\ 0\\.00419800871300536\ \(0\)\
\-\ closed\\:\\ 0\\.004156211753764665\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.004156211753764665\ \(0\)\
\-\ 43\\:\\ 0\\.004142700633041808\ \(0\)\
\-\ 2004\\:\\ 0\\.004129389684447791\ \(0\)\
\-\ adequate\\:\\ 0\\.004116273063224833\ \(0\)\
\-\ 7\\.\\:\\ 0\\.004090600671091809\ \(0\)\
\-\ of\\:\\ 0\\.0040823434241882735\ \(0\)\
\-\ 2001\\:\\ 0\\.004078034415948287\ \(0\)\
\-\ percutaneous\\:\\ 0\\.004065641493996503\ \(0\)\
\-\ approach\\:\\ 0\\.004029456499263403\ \(0\)\
\-\ common\\:\\ 0\\.004018449617172322\ \(0\)\
\-\ 29\\:\\ 0\\.004006118236547086\ \(0\)\
\-\ duty\\:\\ 0\\.004006118236547086\ \(0\)\
\-\ f\\:\\ 0\\.004006118236547086\ \(0\)\
\-\ radiologic\\:\\ 0\\.003994672570978865\ \(0\)\
\-\ meningitis\\:\\ 0\\.00398337087986758\ \(0\)\
\-\ that\\:\\ 0\\.003978384713096559\ \(0\)\
\-\ patients\\:\\ 0\\.003974078345671206\ \(0\)\
\-\ nonspecific\\:\\ 0\\.003950294533845373\ \(0\)\
\-\ am\\:\\ 0\\.003950294533845373\ \(0\)\
\-\ p\\:\\ 0\\.003939534254378423\ \(0\)\
\-\ rr\\:\\ 0\\.0039183927472713305\ \(0\)\
\-\ fixation\\:\\ 0\\.0038977372951377286\ \(0\)\
\-\ extend\\:\\ 0\\.0038480852927342698\ \(0\)\
\-\ chills\\:\\ 0\\.00383847586855031\ \(0\)\
\-\ d\\:\\ 0\\.003828968133302747\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.0038102492771456566\ \(0\)\
\-\ earlier\\:\\ 0\\.0037919124652577795\ \(0\)\
\-\ metabolic\\:\\ 0\\.0037919124652577795\ \(0\)\
\-\ epidural\\:\\ 0\\.0037828825139069244\ \(0\)\
\-\ six\\:\\ 0\\.0037739424143083907\ \(0\)\
\-\ complication\\:\\ 0\\.0037650903959409046\ \(0\)\
\-\ 65\\:\\ 0\\.003747643777920149\ \(0\)\
\-\ denied\\:\\ 0\\.0037390458884177676\ \(0\)\
\-\ localized\\:\\ 0\\.0037390458884177676\ \(0\)\
\-\ place\\:\\ 0\\.0037305294967245567\ \(0\)\
\-\ night\\:\\ 0\\.0037305294967245567\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.0037305294967245567\ \(0\)\
\-\ 6\\.\\:\\ 0\\.0037305294967245567\ \(0\)\
\-\ completely\\:\\ 0\\.003689117899958818\ \(0\)\
\-\ orthopedic\\:\\ 0\\.0036651572107565165\ \(0\)\
\-\ become\\:\\ 0\\.00365731023863724\ \(0\)\
\-\ into\\:\\ 0\\.0036537760430542803\ \(0\)\
\-\ fevers\\:\\ 0\\.0036495312065230314\ \(0\)\
\-\ painful\\:\\ 0\\.0036495312065230314\ \(0\)\
\-\ remainder\\:\\ 0\\.003619071591360694\ \(0\)\
\-\ reduction\\:\\ 0\\.003619071591360694\ \(0\)\
\-\ able\\:\\ 0\\.003619071591360694\ \(0\)\
\-\ 3\\:\\ 0\\.0035956433543693437\ \(0\)\
\-\ period\\:\\ 0\\.0035896108341073327\ \(0\)\
\-\ recently\\:\\ 0\\.003582394147946269\ \(0\)\
\-\ improvement\\:\\ 0\\.003582394147946269\ \(0\)\
\-\ despite\\:\\ 0\\.003568132378713304\ \(0\)\
\-\ urinary\\:\\ 0\\.003554093458764444\ \(0\)\
\-\ be\\:\\ 0\\.0035519049146736635\ \(0\)\
\-\ was\\:\\ 0\\.0035517610861228637\ \(0\)\
\-\ complaint\\:\\ 0\\.003547155411959493\ \(0\)\
\-\ those\\:\\ 0\\.00349349931609101\ \(0\)\
\-\ incidentally\\:\\ 0\\.0034805714297908305\ \(0\)\
\-\ lower\\:\\ 0\\.003453480807482233\ \(0\)\
\-\ numerous\\:\\ 0\\.0034428677468626794\ \(0\)\
\-\ clinic\\:\\ 0\\.003430643441331881\ \(0\)\
\-\ intervention\\:\\ 0\\.0034185832254000383\ \(0\)\
\-\ open\\:\\ 0\\.0034126132858504706\ \(0\)\
\-\ 14\\:\\ 0\\.003383344489413263\ \(0\)\
\-\ their\\:\\ 0\\.003360597132733757\ \(0\)\
\-\ complaints\\:\\ 0\\.0033329496406701866\ \(0\)\
\-\ four\\:\\ 0\\.0033329496406701866\ \(0\)\
\-\ near\\:\\ 0\\.0033221245386790147\ \(0\)\
\-\ 5\\.\\:\\ 0\\.003311428310012062\ \(0\)\
\-\ continued\\:\\ 0\\.003306127571353312\ \(0\)\
\-\ room\\:\\ 0\\.00330085792224963\ \(0\)\
\-\ \\-\\:\\ 0\\.003291515649071633\ \(0\)\
\-\ last\\:\\ 0\\.0032800830638301747\ \(0\)\
\-\ characteristic\\:\\ 0\\.003249794602606175\ \(0\)\
\-\ compared\\:\\ 0\\.003249794602606175\ \(0\)\
\-\ features\\:\\ 0\\.003239921178009953\ \(0\)\
\-\ taken\\:\\ 0\\.0032014779837554975\ \(0\)\
\-\ references\\:\\ 0\\.003192118809579167\ \(0\)\
\-\ done\\:\\ 0\\.003182856123452607\ \(0\)\
\-\ formation\\:\\ 0\\.0031691387181239563\ \(0\)\
\-\ initially\\:\\ 0\\.0031248700307863254\ \(0\)\
\-\ treatment\\:\\ 0\\.003108026881582906\ \(0\)\
\-\ typical\\:\\ 0\\.003078568458355793\ \(0\)\
\-\ additional\\:\\ 0\\.003078568458355793\ \(0\)\
\-\ patient\\:\\ 0\\.0030784975055395797\ \(0\)\
\-\ complications\\:\\ 0\\.0030423834636226933\ \(0\)\
\-\ seen\\:\\ 0\\.003034371275952723\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0030228930551669344\ \(0\)\
\-\ hours\\:\\ 0\\.0030190452009063763\ \(0\)\
\-\ pressure\\:\\ 0\\.003015213755455831\ \(0\)\
\-\ extremities\\:\\ 0\\.0030113985794617145\ \(0\)\
\-\ causes\\:\\ 0\\.002988841597313398\ \(0\)\
\-\ 24\\:\\ 0\\.0029851365504276277\ \(0\)\
\-\ rare\\:\\ 0\\.0029814467193830154\ \(0\)\
\-\ 30\\:\\ 0\\.0029524612187377137\ \(0\)\
\-\ active\\:\\ 0\\.0029313197116306207\ \(0\)\
\-\ cord\\:\\ 0\\.0029174967836526518\ \(0\)\
\-\ course\\:\\ 0\\.0028971531387741614\ \(0\)\
\-\ tumors\\:\\ 0\\.002883842190180145\ \(0\)\
\-\ has\\:\\ 0\\.0028835578984623147\ \(0\)\
\-\ a\\:\\ 0\\.002850672429962992\ \(0\)\
\-\ laboratory\\:\\ 0\\.0028293726287997\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.002823176241504947\ \(0\)\
\-\ diagnosed\\:\\ 0\\.002823176241504947\ \(0\)\
\-\ ap\\:\\ 0\\.0028078696941980573\ \(0\)\
\-\ reported\\:\\ 0\\.0027988093895559858\ \(0\)\
\-\ peripheral\\:\\ 0\\.0027780173603001953\ \(0\)\
\-\ male\\:\\ 0\\.0027766496637690445\ \(0\)\
\-\ later\\:\\ 0\\.0027721640979271552\ \(0\)\
\-\ nerve\\:\\ 0\\.0027663487210128537\ \(0\)\
\-\ required\\:\\ 0\\.0027634550869607044\ \(0\)\
\-\ muscle\\:\\ 0\\.0027576956275169318\ \(0\)\
\-\ weight\\:\\ 0\\.002751972852777058\ \(0\)\
\-\ spinal\\:\\ 0\\.0027491250767112184\ \(0\)\
\-\ identified\\:\\ 0\\.002743456461083847\ \(0\)\
\-\ palpable\\:\\ 0\\.0027211330122190393\ \(0\)\
\-\ signs\\:\\ 0\\.002702044864318108\ \(0\)\
\-\ or\\:\\ 0\\.0026995222344035246\ \(0\)\
\-\ new\\:\\ 0\\.002675460895597986\ \(0\)\
\-\ given\\:\\ 0\\.0026319985557199843\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0026270208554723517\ \(0\)\
\-\ does\\:\\ 0\\.0026196056337682\ \(0\)\
\-\ week\\:\\ 0\\.002607381328237402\ \(0\)\
\-\ on\\:\\ 0\\.0026015849501003704\ \(0\)\
\-\ air\\:\\ 0\\.0025977202394896373\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.002595321112305559\ \(0\)\
\-\ although\\:\\ 0\\.002592928374282663\ \(0\)\
\-\ three\\:\\ 0\\.002588161930230827\ \(0\)\
\-\ 10\\:\\ 0\\.002588161930230827\ \(0\)\
\-\ internal\\:\\ 0\\.002574012463053703\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0025554865985409126\ \(0\)\
\-\ density\\:\\ 0\\.0025261737258400353\ \(0\)\
\-\ joint\\:\\ 0\\.002482865458258833\ \(0\)\
\-\ 2\\.\\:\\ 0\\.00244154909416016\ \(0\)\
\-\ area\\:\\ 0\\.0024275258258169515\ \(0\)\
\-\ abscess\\:\\ 0\\.0024275258258169515\ \(0\)\
\-\ normal\\:\\ 0\\.002407210161004674\ \(0\)\
\-\ such\\:\\ 0\\.0024001193080331108\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0023981933210221033\ \(0\)\
\-\ medical\\:\\ 0\\.0023623628032938045\ \(0\)\
\-\ show\\:\\ 0\\.0023568337237121527\ \(0\)\
\-\ brain\\:\\ 0\\.0023102888798766956\ \(0\)\
\-\ only\\:\\ 0\\.0023085459644967975\ \(0\)\
\-\ 6\\:\\ 0\\.002293010028189465\ \(0\)\
\-\ there\\:\\ 0\\.0022852031562713183\ \(0\)\
\-\ from\\:\\ 0\\.0022757155672133195\ \(0\)\
\-\ loss\\:\\ 0\\.002228629085775777\ \(0\)\
\-\ when\\:\\ 0\\.0021988600517664023\ \(0\)\
\-\ appearance\\:\\ 0\\.0021957830878118973\ \(0\)\
\-\ abnormal\\:\\ 0\\.0021896605932748532\ \(0\)\
\-\ through\\:\\ 0\\.0021805543741427393\ \(0\)\
\-\ following\\:\\ 0\\.0021790456036847694\ \(0\)\
\-\ head\\:\\ 0\\.0021775393626000863\ \(0\)\
\-\ 4\\:\\ 0\\.0021392380100440657\ \(0\)\
\-\ an\\:\\ 0\\.002123386997816226\ \(0\)\
\-\ history\\:\\ 0\\.0021207808404439953\ \(0\)\
\-\ trauma\\:\\ 0\\.0020997383483898737\ \(0\)\
\-\ significant\\:\\ 0\\.0020645526963649808\ \(0\)\
\-\ lesions\\:\\ 0\\.0020553104279819835\ \(0\)\
\-\ evidence\\:\\ 0\\.0020129762653790456\ \(0\)\
\-\ \\.\\:\\ 0\\.002009407703623374\ \(0\)\
\-\ these\\:\\ 0\\.0019980635147869184\ \(0\)\
\-\ both\\:\\ 0\\.001960646891901277\ \(0\)\
\-\ more\\:\\ 0\\.0019201943479893679\ \(0\)\
\-\ symptoms\\:\\ 0\\.0019134388831070434\ \(0\)\
\-\ physical\\:\\ 0\\.0018836525333164765\ \(0\)\
\-\ consistent\\:\\ 0\\.0018825680762185116\ \(0\)\
\-\ bilateral\\:\\ 0\\.001863268400102825\ \(0\)\
\-\ imaging\\:\\ 0\\.0017988084676150969\ \(0\)\
\-\ posterior\\:\\ 0\\.001769666261188184\ \(0\)\
\-\ other\\:\\ 0\\.001769666261188184\ \(0\)\
\-\ small\\:\\ 0\\.0017687109473325416\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0017630002971971428\ \(0\)\
\-\ well\\:\\ 0\\.0017368202632243046\ \(0\)\
\-\ \\'s\\:\\ 0\\.0016927642572929426\ \(0\)\
\-\ exam\\:\\ 0\\.0016866432524254612\ \(0\)\
\-\ may\\:\\ 0\\.0016840326764583323\ \(0\)\
\-\ with\\:\\ 0\\.0016820007344458543\ \(0\)\
\-\ but\\:\\ 0\\.0016374692731658022\ \(0\)\
\-\ findings\\:\\ 0\\.0016341751444653727\ \(0\)\
\-\ multiple\\:\\ 0\\.0016170763732967375\ \(0\)\
\-\ surgical\\:\\ 0\\.0016138560379617734\ \(0\)\
\-\ within\\:\\ 0\\.0014646283992687168\ \(0\)\
\-\ which\\:\\ 0\\.0014331936992296036\ \(0\)\
\-\ not\\:\\ 0\\.0011094507383126104\ \(0\)\
\-\ mass\\:\\ 0\\.0010677996468531578\ \(0\)\
\-\ at\\:\\ 0\\.0010402184661560045\ \(0\)\
\-\ this\\:\\ 0\\.0008635554477215931\ \(0\)\
\-\ year\\:\\ 0\\.0008590343838930052\ \(0\)\
\-\ old\\:\\ 0\\.0007861047590855837\ \(0\)\
\-\ no\\:\\ 0\\.000773085490299912\ \(0\)\
